Pdt Partners, LLC Pacific Biosciences Of California, Inc. Transaction History

Pdt Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$26.38 - $51.15 $519,976 - $1.01 Million	-19,711 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $206,965 - $561,763	19,711 New	19,711 $511,000
Q3 2020 Nov 16, 2020	SELL	$3.61 - $9.87 $63,882 - $174,659	-17,696 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.65 - $4.03 $46,894 - $71,314	17,696 New	17,696 $61,000
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $1.14 Million - $2.24 Million	-286,310 Closed	0 $0

Q3 2018 Nov 14, 2018	BUY	$3.52 - $5.55 $417,155 - $657,730	118,510 Added 70.63%	286,310 $1.55 Million
Q1 2018 May 15, 2018	SELL	$2.05 - $3.23 $183,269 - $288,762	-89,400 Reduced 34.76%	167,800 $344,000
Q4 2017 Feb 14, 2018	SELL	$2.59 - $5.44 $356,384 - $748,544	-137,600 Reduced 34.85%	257,200 $679,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $1.26 Million - $2.2 Million	394,800	394,800 $2.07 Million

293

253M

1.42M

1.18M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $288M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.